Abbott Releases ID NOW ™ COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health

- Data show ID NOW performance of 95.0% sensitivity and 97.9% specificity within seven days of symptom onset
Source: Abbott.com - Category: Pharmaceuticals Source Type: news